Asthma flare-ups: what a written action plan should contain
A written asthma action plan is a personalised set of instructions for recognising and responding to worsening asthma. It should name the person’s regular and reliever medicines, describe their early warning signs, state what their clinician has told them to change, and explain when to obtain urgent or emergency help. A generic online plan cannot safely supply those individual instructions.
Key takeaways
- The plan must match the exact inhalers and regimen: instructions differ for a short-acting reliever, an anti-inflammatory reliever and maintenance-and-reliever therapy.
- Early worsening can appear as more symptoms, night waking, activity limitation or increasing reliever use before an attack becomes severe.
- Severe breathlessness, difficulty speaking, drowsiness, confusion, blue or grey colour, a silent chest or failure to respond as the plan expects requires urgent emergency assessment.
What information belongs in a written asthma action plan?
The 2026 Global Initiative for Asthma strategy says all patients should receive a written, digital or pictorial action plan appropriate to their age, treatment regimen, reliever inhaler, asthma control and health literacy. The useful part is specificity. A plan should make clear:
- which medicine is used regularly and which is used when symptoms worsen;
- the person’s usual signs that control is deteriorating;
- the clinician-set instructions for changing reliever or maintenance treatment;
- whether peak expiratory flow is part of that person’s plan and what their own thresholds mean;
- when to contact a clinic, attend urgent care or call an ambulance;
- who needs a copy, such as a parent, caregiver, school or workplace first aider.
Singapore HealthHub’s asthma guidance describes the plan as a personalised written list covering daily medicines, warning symptoms, what to use when symptoms worsen and when to call for help. It is a working safety document, not a generic asthma diary.
Why can two people with asthma have different instructions?
The word “reliever” no longer identifies one universal medicine pattern. One person may have a short-acting bronchodilator such as salbutamol. Another may have an eligible inhaled-corticosteroid and formoterol combination serving as an anti-inflammatory reliever or as both maintenance and reliever treatment. The 2026 GINA strategy also recognises combination ICS-SABA relievers in some settings.
That means an instruction copied from another patient, an old plan or a colour-based inhaler chart can be wrong even when both people use the word “asthma”. The current reliever versus preventer inhaler guide explains why ingredients and prescribed role matter more than device colour.
| Plan element | What must be individualised | Why a generic instruction fails |
|---|---|---|
| Regular treatment | Ingredient, device, strength and prescribed schedule | Different controller and MART regimens do not use the same worsening steps |
| Reliever | Exact ingredient and role | A maintenance-only combination is not automatically a reliever |
| Early-warning signs | The person’s usual symptoms and functional changes | Wheeze may be absent; patterns differ by age and patient |
| Peak flow | Whether it is used and the person’s own reference values | A universal number ignores personal best and clinical context |
| Escalation | Named clinic, urgent-care and emergency steps | Access, history and risk of rapid deterioration differ |
What can signal that asthma is worsening?
A flare-up is an acute or sub-acute worsening from the person’s usual symptoms and lung function. Early signals may include more cough, wheeze, chest tightness or breathlessness; symptoms at night; reduced ability to exercise or complete usual activities; or needing the prescribed reliever more often. For some adults, a clinician may include falling peak-flow readings as another signal.
None of these observations tells a reader to invent a medicine change. Their purpose is to trigger the instructions already written into the plan or to prompt review when the plan is missing or out of date.
An unexpected increase in reliever use can also expose another problem: poor device technique, an empty device, missed maintenance treatment, a respiratory infection, smoke or haze exposure, or a diagnosis that needs reassessment. A plan should therefore be reviewed alongside the actual inhalers, not from a medicine list alone.
Why do inhaler technique and supply belong in the plan review?
An appropriate medicine cannot work as intended if little reaches the lungs. Metered-dose inhalers require coordination, while dry-powder and other devices have different inhalation requirements. HealthHub’s metered-dose inhaler guide shows why a spacer may help with specific coordination problems, but it does not apply unchanged to every device.
At a review, bring every inhaler and spacer. Ask the clinician or pharmacist to watch the technique, confirm the counter or remaining doses, identify expired or duplicate devices and write the ingredient names into the plan. The plan also needs updating after a regimen change; keeping the old inhaler colours on the page creates avoidable ambiguity.
What changes the answer?
- Age and communication. A child’s plan must work for parents, teachers and caregivers; a pictorial plan may be more useful than dense text.
- The reliever regimen. SABA, ICS-formoterol and ICS-SABA plans have different clinician-set worsening instructions.
- Previous severe or rapid attacks. A history of sudden deterioration may require earlier acute assessment and a lower threshold for help.
- Peak-flow use. Symptom-based plans suit many people; adults who use peak flow need their own reference values and correct meter technique.
- Pregnancy and other conditions. Maintaining asthma control remains important, but the action plan should reflect the individual clinical review.
- Where the person spends time. Family, school, travel and work arrangements affect who holds the plan and how emergency medicines are accessed.
Which signs need emergency help?
Follow the emergency section of the individual action plan. Call emergency services when breathing is rapidly worsening or severe, the person cannot speak normally because of breathlessness, the prescribed reliever is not helping as the plan expects, or the lips or face appear blue or grey. Drowsiness, confusion or a “silent chest” are danger signs identified in current GINA guidance and require immediate acute care.
Do not wait for a peak-flow measurement when the person is severely unwell, and do not substitute an online dose schedule for emergency assessment. If features of a severe allergic reaction occur at the same time, such as facial or tongue swelling or collapse, tell emergency services because asthma and anaphylaxis require different immediate treatment priorities.
What should happen after a flare-up or near miss?
The plan needs review after urgent treatment, repeated worsening or any occasion when the instructions were unclear. The review should check what happened before the flare, which inhalers were actually used, technique, adherence, side effects, triggers, whether anti-inflammatory treatment is appropriate and whether follow-up has been arranged.
If no written plan exists, ask for one at the next asthma review and bring all devices. The asthma condition page and the inhaler-role guide can help identify the questions, but only the treating clinician can fill in the personal medicine-change and emergency instructions.
Sources
- Global Initiative for Asthma: 2026 GINA Strategy Report.
- Singapore HealthHub: Asthma.
- Singapore HealthHub: Metered Dose Inhalers.
- KK Women’s and Children’s Hospital: Asthmatic but active—helping children with asthma lead a healthy lifestyle.
